Last Updated on
July 26, 2022
Private equity and venture capital firms play a pivotal role in introducing innovative and affordable solutions to health infrastructure. They do so by supporting startups that bring transformative and revolutionary alternative solutions to fatal disease problems.
Polaris Partners is one such investment firm that’s committed to building companies working on life-changing solutions. They partner with healthcare founders and support them in their entrepreneurial journey towards developing approaches that accelerate and scale-up medical operations—benefiting people’s health.
The firm has a particular interest in healthcare, software, and biotech startups. It helps them across all stages of entrepreneurship, from founding the company to guiding them towards professional growth.
Terry McGuire, Jon Flint, and Steve Arnold are the founding partners of Polaris Partners, who established the company in 1996 (earlier known by the name of Polaris Venture Partners). Today, the company has headquarters in three different cities of the United States: Boston, San Francisco, and New York.
Polaris Partners has a team of entrepreneurs, scientists, and operators that help shape transformative early-stage companies. The company’s key players are its managing partners, David Barrett, Brian Chee, Amir Nashat, and Bryce Youngren. Together, they focus on doing what’s best for the company’s growth in the investment space.
In this article, you will learn about the types of funds provided by Polaris Partners and the companies they have supported in the healthcare market.
Polaris’ main funds provide capital to life sciences, healthcare, and biopharmaceutical companies. Its top-funded companies include those in which co-investments have been made with the Polaris Growth Fund and the Polaris Innovation Funds.
Either directly or indirectly, Polaris Partners has invested in hundreds of companies through its main funds by implementing a growth buyout strategy. Some of the companies benefited by this fund are:
The Polaris Innovation Fund helps companies establish, grow, and strengthen their therapeutic and commercial potential of early-stage scientific research. As the name suggests, this fund is dedicated to backing companies who are not yet fully established, but have the potential to create innovative solutions to varying real-world problems.
The leaders working on implementing this active investment model are experts in venture capital investment, scientific research, and biopharma. They provide guidance at every development stage of biomedical innovations, ensuring their prompt time to market.
Some early-stage companies and biomedical innovation supported by the Polaris innovation fund include:
The Polaris Growth Fund is for well-established ventures that have built their leadership position and reputation in the market for their products.
Companies that benefit from the Polaris Growth Fund are primarily in the technology business industries. Some example companies in this category include:
Polaris Partners is a venture capital firm providing financial services and support to healthcare and technology companies in different stages of their growth. Founded in 1996, the company is led by experts in diverse areas including technology, healthcare, scientific research, and venture capital investment.
The company has three main types of funds:
Earning financial support from venture capital firms is very challenging and can take years. Unfortunately, a lack of funds will cause labs of any size to fall behind in their research work; these labs may even be forced to work with instruments and resources ill-equipped for their needs.
If you’ve recently closed your first round of fundraising, whether it’s pre-seed, seed, or a Series A, use the capital you’ve raised wisely by leasing big-ticket items like cutting-edge technology. Doing so can help you extend your cash runway too. If you’ve yet to raise around, keep leasing in mind while you do, as it is an excellent solution to pair with venture capital financing.
We provide labs of all sizes with customizable leasing solutions, perfect for outfitting your lab with the equipment you need without heavily dipping into essential runway or reserves. Our leasing program allows you to lease a broad range of equipment, from general biology lab instruments to cutting-edge advanced imaging and spectroscopy equipment.
Leasing equipment with Excedr is affordable, flexible, and doesn’t require a huge upfront cost. It’s a simple and effective solution for labs to streamline their breakthrough experiments and stay on the cutting edge. Don’t have the budget to purchase lab equipment outright? Consider leasing through Excedr to save lab time and money. Browse your leasing options today!